Browse studies

Find your next paid study

1 recruiting study matching your filters

A Phase I-II, N-of-1, Open-Label, Prospective Study to Evaluate the Efficacy and Safety of ATL-001 in Adult Patients With Congenital Erythropoietic Porphyria (CEP)

This is a study to investigate the effect of oral ATL-001 (ciclopirox) in CEP (Congenital Erythropoietic Porphyria) patients. During the study, it will be meas…

Congenital Erythropoietic Porphyria (CEP)

Estimated

~$10 – $8,750

Atlas Molecular PharmaNCT07024316